PTP
FBIO icon

Platform Technology Partners’s Fortress Biotech FBIO Stock Holding History

Platform Technology Partners’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,000
Closed -$8.71K – 213
2023
Q3 		$8.71K Buy
+2,000
New +$13.7K ﹤0.01% 201

Other funds holding FBIO

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Platform Technology Partners's FBIO Position: Q4 2023 in Review

Platform Technology Partners sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 2,000 shares — an estimated $8.71K sold.

Platform Technology Partners first reported a position in FBIO in Q3 2023 and held it in 1 quarter. The position peaked at $8.71K in Q3 2023. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.

  • Platform Technology Partners reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
  • Platform Technology Partners sold 2,000 Fortress Biotech shares in Q4 2023, an estimated $8.71K.
  • Platform Technology Partners first reported a position in Fortress Biotech in Q3 2023 and held it in 1 quarter.
  • Platform Technology Partners's Fortress Biotech position peaked at $8.71K in Q3 2023.
  • 42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.

Based on Platform Technology Partners's 13F filing for Q4 2023, filed 13 Feb 2024.